Riccio Family Pharmacy

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutide injectionCompounded · not FDA-approved
• Compounded tabletsCompounded · not FDA-approved
• Brand-name GLP-1 injectionFDA-approved

What they publish

Riccio Family Pharmacy publishes 3 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Not a subscription — a dispensing pharmacy

Medication cost

Compounded injections published from $149/month, compounded tablets from $249/month, and original brand injections from $1,999/month; a $299 to $149 sale price also published (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Is itself the dispensing pharmacy, publishing prices for compounded and brand-name products side by side.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Publishing compounded at $149 and the brand original at $1,999 in the same list is a 13-fold gap stated by the dispenser rather than by a marketer.
• Also offers compounded tablets, an oral route further removed from the injectable products the trials studied.
• A community pharmacy publishing prices at all is rare — it lets you sanity-check what any clinic charges on top.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• You still need a prescription; this is dispensing, not prescribing.
• Compounded oral tablets are further from the trial evidence than compounded injectables. Ask what supports the formulation.
• Ask whether it is a 503A or 503B facility.